You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. VASCULAR STAPLER

    SBC: ABIOMED, INC.            Topic: N/A

    THE OBJECTIVE OF THIS PROGRAM IS TO DESIGN AND BUILD A STAPLER FOR PERFORMING END-TO-END AND END-TO-SIDE ANASTOMOSES ON MEDIUM TO LARGE VESSELS, AND FOR REPAIRING BLOOD VESSELS AND VASCULAR ANEURYSMS, AND TO DEVELOP A SURGICAL PROTOCOL FOR ITS USE. THE METHOD PROPOSED USES A SPECIAL STAPLER AND CONFIGURATION OF STAPLES WHICH MINIMIZESBLOOD CONTACT WITH THE STAPLES, DOES NOT RESTRICT THE FLOW OF BL ...

    SBIR Phase I 1988 Department of Health and Human Services
  2. ULTRAMINIATURE IMPLANTABLE ELECTRICAL CONNECTOR

    SBC: ABIOMED, INC.            Topic: N/A

    N/A

    SBIR Phase I 1988 Department of Health and Human Services
  3. A universal TET system for implanted life support systems

    SBC: ABIOMED, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The ultimate objective of this proposed program is the commercialization of a universal transcutaneous energy transfer (TET) system with a high performance implantable battery. This integrated power system will be adapt able to a host of next generation fully implantable mechanical circulatory support (MCS) systems. To date, fully implantable systems (i.e. the ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  4. SBIR Phase I: PolyRNA- A Radical Innovation for Healing the Human Body

    SBC: Ablitech, Inc.            Topic: BT

    This Small Business Innovation Research (SBIR) Phase I project will demonstrate the feasibility of a platform technology for cancer therapy which overcomes the inherent shortcomings of other attempts to delivery siRNA to cancer cells. The difficulty with current siRNA delivery is that the enzymes in the body degrade the siRNA before it can reach its target. Most current siRNA technologies on the m ...

    SBIR Phase I 2008 National Science Foundation
  5. Integration of Lumbar Extensor Muscle Strengthening with Ergonomic Seating

    SBC: ABOVE FITNESS PRODUCTS, LTD            Topic: N/A

    DESCRIPTION (provided by applicant): This grant proposes an innovative approach to prevent low back pain and injury associated with prolonged seating. Specifically, we propose to integrate lumbar extensor muscle strengthening with ergonomic task seating. By doing so, we will provide the public with a means to address two primary causes of low back pain and injury: 1) poor or prolonged seating po ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  6. SUPPORTED MOLTEN SALT CATALYSIS OF ENDOTHERMIC REACTION OF HIGH ENERGY-DENSITY AVIATION FUELS

    SBC: Accel Catalysis Inc.            Topic: N/A

    THE PROPOSED WORK INVOLVES APPLICATION OF SUPPORTED MOLTEN SALT CATALYSIS TO THE CATALYTIC ENDOTHERMIC DEHYDROGENATION OF HIGH ENERGY-DENSITY AVIATION FUELS. THE CATALYSTS OF INTEREST ARE HETEROGENEOUSLY DISPERSED PLATINUM AND NICKEL, TO BE USED ALONE OR IN BIMETALLIC CLUSTERS. THE MOLTEN SALTS TO BE USED INCLUDE BINARY AND TERNARY EUTECTICS INVOLVING ALKALI METAL CHLORIDES AND HYDROXIDES. THE SUP ...

    SBIR Phase I 1988 Department of DefenseAir Force
  7. SUPPORTED MOLTEN SALT DEHYDROGENTATION OF METHANOL

    SBC: Accel Catalysis Inc.            Topic: N/A

    N/A

    SBIR Phase I 1988 Department of DefenseAir Force
  8. Patient-specific therapy of glioblastoma using lightly-labeled [14C]-temozolomide

    SBC: ACCIUM BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): It is widely accepted that the existing clinical paradigm of one treatment fits all is a major factor in the lack of progress in the effective treatment of a highly heterogeneous diseases. We propose a new innovative cl inical paradigm that optimizes brain cancer therapy using patient-specific markers of therapeutic response. Our long-term objective is to impro ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  9. Novel Catheter for Treatment of Ventricular Tachycardia

    SBC: Thermedical Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Ischemic ventricular tachycardia (VT) is a contributing cause to more than half of the 300,000 sudden cardiac deaths that occur annually in the United States. Implantable cardioverter defibrillators (ICDs) are the stand ard therapy but they are expensive the total cost of an ICD implant approaches 50,000 and the United States spends more than 2.2B on these im ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  10. Demand Driven Healthcare Scheduling using Flexible Shifts and Monte Carlo Simulat

    SBC: Acme Express, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The shortage of healthcare workers is accelerating. An longer-living, ageing population is demanding more medical service while healthcare worker retirements and high turnover is decreasing the worker pool. Shortages ca n be reduced or eliminated by scheduling only the number of staff needed to meet the hour-by-hour demand for medical service and using flexible ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government